Comparison between 2D and 3D dosimetry protocols in 90Y-ibritumomab tiuxetan radioimmunotherapy of patients with non-Hodgkin's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/18298329

Download in:

View as

General Info

PMID
18298329